Site ES34006

Madrid 28050

2 studies enrolling now · 6 studies all time

What they study most

Advanced Solid Tumors, Anaplastic Lymphoma Kinase (ALK) Positive, Metastatic Castration-resistant Prostate Cancer (mCRPC), Metastatic Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer, Non-small Cell Lung Cancer (NSCLC), Pancreatic Cancer, Solid Tumor

Studies at this site

• A Study of ASP3082 in Adults With Advanced Solid Tumors — Recruiting now
• A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC) — Recruiting now
• A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer — Running, not enrolling
• A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors — Completed
• A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations — Stopped early
• A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide — Completed